期刊
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
卷 60, 期 5, 页码 462-465出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAI.0b013e31825ddcfa
关键词
stavudine concentrations; breast milk; mother-to-child transmission; HIV
资金
- National Institute of Allergy and Infectious Diseases (NIAID/NIH) [R01-AI087139]
- International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network [UM1-AI068632]
- HIV Prevention Trials Network (HPTN)
- NIAID
- National Institute on Drug Abuse
- National Institute of Mental Health
- Office of AIDS Research, of the NIH, Department of Health and Human Services [UM1-AI068613]
First-line antiretroviral treatment regimens in resource-limited settings used in breastfeeding mothers often include stavudine (d4T). Limited data describing d4T concentrations in breast milk are available. We analyzed d4T concentrations in 52 mother-infant pairs using ultra-performance liquid chromatography-tandem mass spectrometry (lower limit of quantification: 5 ng/mL in plasma, 20 ng/mL in breast milk). Median (interquartile range) d4T concentrations were 86 (36-191) ng/mL in maternal plasma, 151 (48-259) ng/mL in whole milk, 190 (58-296) ng/mL in skim milk, and <5 (<5 to <5) ng/mL in infant plasma. Although d4T is concentrated in breast milk relative to maternal plasma, the infant d4T dose received from breast milk is very small and not clinically significant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据